ARTICLE | Clinical News
Celsentri maraviroc regulatory update
June 25, 2007 7:00 AM UTC
PFE received an approvable letter from FDA for Celsentri maraviroc for use in combination with other antiretroviral agents for treatment-experienced adult patients infected with CC chemokine receptor...